Abstracts Division 1
26. The effect of SGLT-2 inhibitor dapagliflozin on substrate metabolism in humans with prediabetes
A. Veelen1,C. Andriessen1, E. Moonen-Kornips1, J. Jörgensen1, B. Havekes2, E. Phielix1, V.B. Schrauwen-Hinderling1,3, P. Schrauwen1
1Department of Nutrition and Movement Sciences, NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University, Maastricht, the Netherlands
2Internal Medicine, Maastricht University Medical Centre, Maastricht, the Netherlands.3Department of Radiology and Nuclear Medicine, Maastricht University Medical Center, Maastricht, the Netherlands
CONFIDENTIAL DATA
This abstract will not be published online due to data confidentiality.
NUTRIM | School of Nutrition and Translational Research in Metabolism
NUTRIM aims to contribute to health maintenance and personalised medicine by unraveling lifestyle and disease-induced derangements in metabolism and by developing targeted nutritional, exercise and drug interventions. This is facilitated by a state of the art research infrastructure and close interaction between scientists, clinicians, master and PhD students.
www.maastrichtuniversity.nl/nutrim